Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis

Pol Arch Intern Med. 2023 Nov 29;133(11):16586. doi: 10.20452/pamw.16586. Epub 2023 Oct 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Cladribine / therapeutic use
  • Histiocytosis, Langerhans-Cell* / drug therapy
  • Humans

Substances

  • Cladribine
  • Antineoplastic Agents